Envestnet Portfolio Solutions’s Encompass Health EHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.37M Buy
13,571
+368
+3% +$38.1K 0.01% 592
2026
Q1
$1.28M Sell
13,203
-1,749
-12% -$179K 0.01% 563
2025
Q4
$1.59M Buy
14,952
+90
+0.6% +$10.4K 0.01% 608
2025
Q3
$1.89M Sell
14,862
-1,531
-9% -$182K 0.01% 539
2025
Q2
$2.01M Buy
16,393
+10,082
+160% +$1.15M 0.01% 563
2025
Q1
$639K Sell
6,311
-3,177
-33% -$310K ﹤0.01% 954
2024
Q4
$876K Buy
9,488
+716
+8% +$70.3K ﹤0.01% 986
2024
Q3
$848K Buy
8,772
+1,496
+21% +$134K ﹤0.01% 958
2024
Q2
$624K Buy
7,276
+866
+14% +$72.7K ﹤0.01% 1043
2024
Q1
$529K Buy
6,410
+616
+11% +$45.1K ﹤0.01% 1100
2023
Q4
$387K Sell
5,794
-746
-11% -$48.3K ﹤0.01% 1166
2023
Q3
$439K Buy
+6,540
New +$450K ﹤0.01% 1038

Other funds holding EHC

Envestnet Portfolio Solutions's EHC Position: Q2 2026 in Review

Envestnet Portfolio Solutions increased its Encompass Health (EHC) stake by 2.8% in Q2 2026, buying an estimated $38.1K and bringing the position to 13,571 shares worth $1.37M. The position accounts for 0.01% of the portfolio, ranked #592.

Envestnet Portfolio Solutions first reported a position in EHC in Q3 2023 and has held it in 12 quarters since. The position peaked at $2.01M in Q2 2025. 598 funds tracked by Wall St. Rank hold EHC as of Q2 2026.

  • Envestnet Portfolio Solutions held 13,571 shares of Encompass Health worth $1.37M as of Q2 2026.
  • Envestnet Portfolio Solutions bought 368 Encompass Health shares in Q2 2026, an estimated $38.1K.
  • Encompass Health made up 0.01% of Envestnet Portfolio Solutions's portfolio in Q2 2026, its #592 holding.
  • Envestnet Portfolio Solutions first reported a position in Encompass Health in Q3 2023 and has held it in 12 quarters since.
  • Envestnet Portfolio Solutions's Encompass Health position peaked at $2.01M in Q2 2025.
  • 598 funds tracked by Wall St. Rank held Encompass Health as of Q2 2026.

Based on Envestnet Portfolio Solutions's 13F filing for Q2 2026, filed 20 Jul 2026.